Copyright
©The Author(s) 2021.
World J Crit Care Med. Sep 9, 2021; 10(5): 244-259
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.244
Published online Sep 9, 2021. doi: 10.5492/wjccm.v10.i5.244
Table 4 Inflammatory markers in coronavirus disease 2019 survivors and non-survivors
| Non-survivors (n = 167) | Survivors (n = 94) | P value | |
| IL-6 day 1 (pg/mL) | 112 (70, 137) | 100 (70, 135) | 0.34 |
| IL-6 day 2 | 415 (139, 476) | 350 (78, 423) | 0.016 |
| D-dimer day 1 (ng/mL) | 1125 (647, 2434) | 991 (513, 2196) | 0.04 |
| D-dimer day 2 | 849 (604, 1210) | 1140 (646, 2263) | 0.03 |
| CRP day 1 (mg/L) | 117 (89, 159) | 113 (96, 149) | 0.9 |
| CRP day 2 | 107 (81, 154) | 117 (88, 167) | 0.62 |
| Ferritin day 1 (ng/mL) | 931 (593, 1367) | 960 (609, 1395) | 0.51 |
| Ferritin day 2 | 822 (447, 1432) | 1053 (712, 2057) | 0.05 |
- Citation: Iglesias JI, Vassallo AV, Sullivan JB, Elbaga Y, Patel VV, Patel N, Ayad L, Benson P, Pittiglio M, Gobran E, Clark A, Khan W, Damalas K, Mohan R, Singh SP. Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital. World J Crit Care Med 2021; 10(5): 244-259
- URL: https://www.wjgnet.com/2220-3141/full/v10/i5/244.htm
- DOI: https://dx.doi.org/10.5492/wjccm.v10.i5.244